M. A. Rasku

Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma

S. Rai, K. McMasters, Donald M Miller, 2011, BMC Cancer.

Journal of Translational Medicine Transient T Cell Depletion Causes Regression of Melanoma Metastases

Dianne Miller, K. McMasters, J. Chesney, 2022 .

Transient T cell depletion causes regression of melanoma metastases

K. McMasters, Donald M Miller, J. Chesney, 2008, Journal of Translational Medicine.

A phase II trial of biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, interferon, and digoxin in melanoma matients

Dianne Miller, J. Chesney, D. Laber, 2007 .

Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth

John O Trent, A. Lane, A. Yalçin, 2008, Molecular Cancer Therapeutics.

Computer-Assisted Cognitive-Behavior Therapy for Depression: A Systematic Review and Meta-Analysis.

Jesse H. Wright, M. Thase, Gregory K Brown, 2019, The Journal of clinical psychiatry.